

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of response to food (GO:0032095) | 6.16385839 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.80410012 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.80410012 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.72891867 |
| 5 | cellular response to nitric oxide (GO:0071732) | 5.72235552 |
| 6 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.56781460 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 4.98967075 |
| 8 | respiratory electron transport chain (GO:0022904) | 4.88409319 |
| 9 | cellular response to leptin stimulus (GO:0044320) | 4.83000230 |
| 10 | electron transport chain (GO:0022900) | 4.79443582 |
| 11 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 4.78661472 |
| 12 | negative regulation of appetite (GO:0032099) | 4.61147548 |
| 13 | negative regulation of response to food (GO:0032096) | 4.61147548 |
| 14 | response to leptin (GO:0044321) | 4.59096434 |
| 15 | neurofilament cytoskeleton organization (GO:0060052) | 4.52938074 |
| 16 | viral transcription (GO:0019083) | 4.52132655 |
| 17 | cellular response to oxygen radical (GO:0071450) | 4.46615892 |
| 18 | removal of superoxide radicals (GO:0019430) | 4.46615892 |
| 19 | cellular response to superoxide (GO:0071451) | 4.46615892 |
| 20 | cellular response to cadmium ion (GO:0071276) | 4.42518246 |
| 21 | translational termination (GO:0006415) | 4.32392006 |
| 22 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 4.29295200 |
| 23 | chaperone-mediated protein transport (GO:0072321) | 4.27252323 |
| 24 | sterol catabolic process (GO:0016127) | 4.24761848 |
| 25 | cholesterol catabolic process (GO:0006707) | 4.24761848 |
| 26 | glutamate secretion (GO:0014047) | 4.16182264 |
| 27 | negative regulation of necrotic cell death (GO:0060547) | 4.14358325 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.11543965 |
| 29 | response to nitric oxide (GO:0071731) | 4.06250480 |
| 30 | protein complex biogenesis (GO:0070271) | 4.03937852 |
| 31 | astrocyte development (GO:0014002) | 4.01920982 |
| 32 | ATP biosynthetic process (GO:0006754) | 3.91350101 |
| 33 | cellular response to reactive nitrogen species (GO:1902170) | 3.86396922 |
| 34 | cellular zinc ion homeostasis (GO:0006882) | 3.85088269 |
| 35 | axon ensheathment in central nervous system (GO:0032291) | 3.82805376 |
| 36 | central nervous system myelination (GO:0022010) | 3.82805376 |
| 37 | synaptic vesicle exocytosis (GO:0016079) | 3.81566547 |
| 38 | regulation of protein glycosylation (GO:0060049) | 3.74835160 |
| 39 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.70460738 |
| 40 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.64538823 |
| 41 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.62785718 |
| 42 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.60502246 |
| 43 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.60088013 |
| 44 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.60088013 |
| 45 | NADH dehydrogenase complex assembly (GO:0010257) | 3.60088013 |
| 46 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.50826057 |
| 47 | activation of protein kinase B activity (GO:0032148) | 3.50723799 |
| 48 | translational elongation (GO:0006414) | 3.50658623 |
| 49 | relaxation of smooth muscle (GO:0044557) | 3.50032952 |
| 50 | response to superoxide (GO:0000303) | 3.46600218 |
| 51 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.43005143 |
| 52 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.42828382 |
| 53 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 3.41551704 |
| 54 | protein targeting to ER (GO:0045047) | 3.37347810 |
| 55 | cotranslational protein targeting to membrane (GO:0006613) | 3.37087065 |
| 56 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.35916033 |
| 57 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.35855117 |
| 58 | behavioral response to cocaine (GO:0048148) | 3.34748591 |
| 59 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.34160279 |
| 60 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.34160279 |
| 61 | sleep (GO:0030431) | 3.32980721 |
| 62 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.32756326 |
| 63 | response to oxygen radical (GO:0000305) | 3.30294072 |
| 64 | cellular protein complex disassembly (GO:0043624) | 3.27221084 |
| 65 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.25179833 |
| 66 | protein localization to endoplasmic reticulum (GO:0070972) | 3.22020602 |
| 67 | hydrogen ion transmembrane transport (GO:1902600) | 3.16468115 |
| 68 | zinc ion homeostasis (GO:0055069) | 3.13772418 |
| 69 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.13653667 |
| 70 | oxidative phosphorylation (GO:0006119) | 3.13148527 |
| 71 | positive regulation of potassium ion transport (GO:0043268) | 3.12270814 |
| 72 | neuronal action potential propagation (GO:0019227) | 3.11709382 |
| 73 | cellular potassium ion homeostasis (GO:0030007) | 3.11091117 |
| 74 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.10906390 |
| 75 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.10879466 |
| 76 | urinary tract smooth muscle contraction (GO:0014848) | 3.10568677 |
| 77 | regulation of sensory perception of pain (GO:0051930) | 3.10524288 |
| 78 | regulation of sensory perception (GO:0051931) | 3.10524288 |
| 79 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 3.09744036 |
| 80 | viral life cycle (GO:0019058) | 3.09719814 |
| 81 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.05161862 |
| 82 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.97814243 |
| 83 | regulation of membrane repolarization (GO:0060306) | 2.97515500 |
| 84 | behavioral defense response (GO:0002209) | 2.97022952 |
| 85 | behavioral fear response (GO:0001662) | 2.97022952 |
| 86 | negative regulation of axon extension (GO:0030517) | 2.96524855 |
| 87 | membrane repolarization (GO:0086009) | 2.96230613 |
| 88 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.94537553 |
| 89 | adaptation of signaling pathway (GO:0023058) | 2.93140581 |
| 90 | startle response (GO:0001964) | 2.92872963 |
| 91 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.90854818 |
| 92 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.90854818 |
| 93 | regulation of appetite (GO:0032098) | 2.87637148 |
| 94 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.87028892 |
| 95 | regulation of potassium ion transport (GO:0043266) | 2.83011099 |
| 96 | positive regulation of synapse maturation (GO:0090129) | 2.81411793 |
| 97 | behavioral response to nicotine (GO:0035095) | 2.80224003 |
| 98 | response to histamine (GO:0034776) | 2.80103180 |
| 99 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.79806791 |
| 100 | fear response (GO:0042596) | 2.78665848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.21696277 |
| 2 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.36944705 |
| 3 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 3.01776859 |
| 4 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.91998422 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.86904626 |
| 6 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.80550328 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.75115344 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.68987980 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.61194975 |
| 10 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.60826198 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.60364917 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.55114383 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45614436 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45614436 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43776671 |
| 16 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33054584 |
| 17 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.25375305 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.16648057 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15038807 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13881677 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.12647054 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12436437 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.12002034 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11199384 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.99227931 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95487479 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.92153173 |
| 28 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.90097987 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85548165 |
| 30 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.83355711 |
| 31 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.80273894 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.72701358 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71269395 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.67654168 |
| 35 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.55919620 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52740506 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52034871 |
| 38 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51213654 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50891190 |
| 40 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.45578600 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44307871 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.37130280 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35899301 |
| 44 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34876466 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34128326 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32915402 |
| 47 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.31761118 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29096594 |
| 49 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29024409 |
| 50 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.27518683 |
| 51 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23216771 |
| 52 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21443432 |
| 53 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.19581796 |
| 54 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.19288193 |
| 55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.17945842 |
| 56 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.15798628 |
| 57 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12824229 |
| 58 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.12719319 |
| 59 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.12369924 |
| 60 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.10506005 |
| 61 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07440422 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06491267 |
| 63 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.06039204 |
| 64 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.05143396 |
| 65 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.04116508 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01640093 |
| 67 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98884860 |
| 68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.98554786 |
| 69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.97655487 |
| 70 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94613797 |
| 71 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.94132176 |
| 72 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93688462 |
| 73 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.93524295 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 0.92895296 |
| 75 | EWS_26573619_Chip-Seq_HEK293_Human | 0.90289437 |
| 76 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.89858706 |
| 77 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.88914831 |
| 78 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.87341018 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.87320220 |
| 80 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.85953918 |
| 81 | ERA_21632823_ChIP-Seq_H3396_Human | 0.85132023 |
| 82 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.85071422 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84397969 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84078834 |
| 85 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83313580 |
| 86 | NCOR_22424771_ChIP-Seq_293T_Human | 0.82919632 |
| 87 | JUN_21703547_ChIP-Seq_K562_Human | 0.82374573 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82114608 |
| 89 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.81503277 |
| 90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81466805 |
| 91 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.81313900 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.79850549 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78698705 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.78650893 |
| 95 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.78242813 |
| 96 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.78126041 |
| 97 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.77704335 |
| 98 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.77432593 |
| 99 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.77397470 |
| 100 | AR_25329375_ChIP-Seq_VCAP_Human | 0.76989298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.27788732 |
| 2 | MP0009745_abnormal_behavioral_response | 3.16316118 |
| 3 | MP0009046_muscle_twitch | 3.03307736 |
| 4 | MP0002064_seizures | 3.02400133 |
| 5 | MP0004885_abnormal_endolymph | 2.91894853 |
| 6 | MP0003787_abnormal_imprinting | 2.90763462 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.78737260 |
| 8 | MP0002272_abnormal_nervous_system | 2.67661802 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.64659435 |
| 10 | MP0001188_hyperpigmentation | 2.57673330 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.43844495 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.43318777 |
| 13 | MP0003879_abnormal_hair_cell | 2.41895618 |
| 14 | MP0003880_abnormal_central_pattern | 2.34244314 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.24744103 |
| 16 | MP0003123_paternal_imprinting | 2.22790807 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.19269616 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.04924017 |
| 19 | MP0001905_abnormal_dopamine_level | 2.01675743 |
| 20 | MP0001486_abnormal_startle_reflex | 1.99398045 |
| 21 | MP0010386_abnormal_urinary_bladder | 1.98367921 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.97699706 |
| 23 | MP0002735_abnormal_chemical_nociception | 1.94740892 |
| 24 | MP0002063_abnormal_learning/memory/cond | 1.94521463 |
| 25 | MP0002736_abnormal_nociception_after | 1.91527151 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 1.88143373 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 1.86287461 |
| 28 | MP0004270_analgesia | 1.85586179 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.83421564 |
| 30 | MP0001970_abnormal_pain_threshold | 1.82027677 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.70466192 |
| 32 | MP0001984_abnormal_olfaction | 1.70414328 |
| 33 | MP0002163_abnormal_gland_morphology | 1.67575449 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.66467656 |
| 35 | MP0000955_abnormal_spinal_cord | 1.65151611 |
| 36 | MP0002234_abnormal_pharynx_morphology | 1.64877234 |
| 37 | MP0004043_abnormal_pH_regulation | 1.60983713 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.57417318 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.51053824 |
| 40 | MP0000049_abnormal_middle_ear | 1.49565344 |
| 41 | MP0003011_delayed_dark_adaptation | 1.48575151 |
| 42 | MP0004742_abnormal_vestibular_system | 1.48267425 |
| 43 | MP0001963_abnormal_hearing_physiology | 1.42234341 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.41818024 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.41047207 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.34017190 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.32866760 |
| 48 | MP0002822_catalepsy | 1.30707272 |
| 49 | MP0000631_abnormal_neuroendocrine_gland | 1.27716852 |
| 50 | MP0004142_abnormal_muscle_tone | 1.24265999 |
| 51 | MP0002160_abnormal_reproductive_system | 1.19898016 |
| 52 | MP0002882_abnormal_neuron_morphology | 1.19476709 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.18351266 |
| 54 | MP0003633_abnormal_nervous_system | 1.18198386 |
| 55 | MP0004147_increased_porphyrin_level | 1.14758502 |
| 56 | MP0000026_abnormal_inner_ear | 1.13309777 |
| 57 | MP0003121_genomic_imprinting | 1.12496427 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.11718345 |
| 59 | MP0002184_abnormal_innervation | 1.11504706 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.11186535 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.10266403 |
| 62 | MP0004811_abnormal_neuron_physiology | 1.08130484 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.06382541 |
| 64 | MP0004924_abnormal_behavior | 1.06382541 |
| 65 | MP0002752_abnormal_somatic_nervous | 1.04996957 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.02864111 |
| 67 | MP0001502_abnormal_circadian_rhythm | 1.02522165 |
| 68 | MP0002229_neurodegeneration | 1.01771737 |
| 69 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01740153 |
| 70 | MP0008872_abnormal_physiological_respon | 0.97731002 |
| 71 | MP0000778_abnormal_nervous_system | 0.97607022 |
| 72 | MP0005389_reproductive_system_phenotype | 0.93940622 |
| 73 | MP0003938_abnormal_ear_development | 0.92489212 |
| 74 | MP0003631_nervous_system_phenotype | 0.91235894 |
| 75 | MP0003136_yellow_coat_color | 0.91134154 |
| 76 | MP0008569_lethality_at_weaning | 0.88671891 |
| 77 | MP0001919_abnormal_reproductive_system | 0.87399148 |
| 78 | MP0003186_abnormal_redox_activity | 0.86551858 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 0.85130828 |
| 80 | MP0006072_abnormal_retinal_apoptosis | 0.85001758 |
| 81 | MP0004133_heterotaxia | 0.84720892 |
| 82 | MP0005332_abnormal_amino_acid | 0.84689578 |
| 83 | MP0005377_hearing/vestibular/ear_phenot | 0.83726059 |
| 84 | MP0003878_abnormal_ear_physiology | 0.83726059 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 0.81953036 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.81104947 |
| 87 | MP0004215_abnormal_myocardial_fiber | 0.80601984 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.78183325 |
| 89 | MP0002095_abnormal_skin_pigmentation | 0.77117233 |
| 90 | MP0005499_abnormal_olfactory_system | 0.75182288 |
| 91 | MP0005394_taste/olfaction_phenotype | 0.75182288 |
| 92 | MP0002249_abnormal_larynx_morphology | 0.74301283 |
| 93 | MP0003122_maternal_imprinting | 0.74106974 |
| 94 | MP0005195_abnormal_posterior_eye | 0.72727180 |
| 95 | MP0001664_abnormal_digestion | 0.71944703 |
| 96 | MP0002152_abnormal_brain_morphology | 0.71625468 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.66258316 |
| 98 | MP0005535_abnormal_body_temperature | 0.65670463 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 0.65454826 |
| 100 | MP0003646_muscle_fatigue | 0.65202322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.72549205 |
| 2 | Myokymia (HP:0002411) | 4.70262959 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.64971638 |
| 4 | Progressive macrocephaly (HP:0004481) | 3.92937807 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.92810686 |
| 6 | Acute encephalopathy (HP:0006846) | 3.92419807 |
| 7 | Focal seizures (HP:0007359) | 3.90999902 |
| 8 | Focal motor seizures (HP:0011153) | 3.82902613 |
| 9 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.74241996 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.74241996 |
| 11 | Hyperthyroidism (HP:0000836) | 3.61491808 |
| 12 | Atonic seizures (HP:0010819) | 3.55223683 |
| 13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.53831398 |
| 14 | Congenital malformation of the right heart (HP:0011723) | 3.45152854 |
| 15 | Double outlet right ventricle (HP:0001719) | 3.45152854 |
| 16 | Renal Fanconi syndrome (HP:0001994) | 3.39220049 |
| 17 | Action tremor (HP:0002345) | 3.36414526 |
| 18 | Absence seizures (HP:0002121) | 3.33905155 |
| 19 | Increased CSF lactate (HP:0002490) | 3.33356449 |
| 20 | Epileptic encephalopathy (HP:0200134) | 3.26086720 |
| 21 | Increased muscle lipid content (HP:0009058) | 3.15769042 |
| 22 | Dialeptic seizures (HP:0011146) | 3.13247010 |
| 23 | Febrile seizures (HP:0002373) | 3.10375562 |
| 24 | Increased hepatocellular lipid droplets (HP:0006565) | 3.04639180 |
| 25 | Ventricular fibrillation (HP:0001663) | 2.96746404 |
| 26 | Lipid accumulation in hepatocytes (HP:0006561) | 2.93441559 |
| 27 | Abnormality of renal resorption (HP:0011038) | 2.84919518 |
| 28 | Hypoplastic left heart (HP:0004383) | 2.83397283 |
| 29 | Cerebral edema (HP:0002181) | 2.79089235 |
| 30 | Molar tooth sign on MRI (HP:0002419) | 2.77003975 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 2.77003975 |
| 32 | Macrocytic anemia (HP:0001972) | 2.76951787 |
| 33 | Generalized tonic-clonic seizures (HP:0002069) | 2.66875237 |
| 34 | Truncus arteriosus (HP:0001660) | 2.59460484 |
| 35 | Sclerocornea (HP:0000647) | 2.48043490 |
| 36 | Limb dystonia (HP:0002451) | 2.45989895 |
| 37 | Hepatocellular necrosis (HP:0001404) | 2.45773529 |
| 38 | Leukodystrophy (HP:0002415) | 2.45465615 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 2.44571737 |
| 40 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.42273707 |
| 41 | Congenital stationary night blindness (HP:0007642) | 2.39539306 |
| 42 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.38861951 |
| 43 | Absent/shortened dynein arms (HP:0200106) | 2.38861951 |
| 44 | 3-Methylglutaconic aciduria (HP:0003535) | 2.36541518 |
| 45 | Pancreatic fibrosis (HP:0100732) | 2.35289916 |
| 46 | Abnormality of binocular vision (HP:0011514) | 2.35091986 |
| 47 | Diplopia (HP:0000651) | 2.35091986 |
| 48 | Amblyopia (HP:0000646) | 2.30082319 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.29485934 |
| 50 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.27542308 |
| 51 | Lactic acidosis (HP:0003128) | 2.27387642 |
| 52 | Hepatic necrosis (HP:0002605) | 2.25017086 |
| 53 | Respiratory failure (HP:0002878) | 2.24869789 |
| 54 | Status epilepticus (HP:0002133) | 2.22360626 |
| 55 | Hypoplastic heart (HP:0001961) | 2.21083901 |
| 56 | X-linked dominant inheritance (HP:0001423) | 2.16637503 |
| 57 | Agitation (HP:0000713) | 2.16623759 |
| 58 | Cerebral hypomyelination (HP:0006808) | 2.16366803 |
| 59 | Pigmentary retinal degeneration (HP:0001146) | 2.14707047 |
| 60 | Epileptiform EEG discharges (HP:0011182) | 2.14481984 |
| 61 | Abnormal number of erythroid precursors (HP:0012131) | 2.10585285 |
| 62 | Hyperphosphaturia (HP:0003109) | 2.10405837 |
| 63 | Exertional dyspnea (HP:0002875) | 2.09612749 |
| 64 | Periauricular skin pits (HP:0100277) | 2.08776861 |
| 65 | Preauricular pit (HP:0004467) | 2.08776861 |
| 66 | Abnormality of urine glucose concentration (HP:0011016) | 2.06699138 |
| 67 | Glycosuria (HP:0003076) | 2.06699138 |
| 68 | Syncope (HP:0001279) | 2.06306858 |
| 69 | Visual hallucinations (HP:0002367) | 2.05781871 |
| 70 | Nephronophthisis (HP:0000090) | 2.02586082 |
| 71 | Anxiety (HP:0000739) | 2.01597615 |
| 72 | Abnormal drinking behavior (HP:0030082) | 1.97860096 |
| 73 | Polydipsia (HP:0001959) | 1.97860096 |
| 74 | Exercise intolerance (HP:0003546) | 1.97831338 |
| 75 | Optic disc pallor (HP:0000543) | 1.97685358 |
| 76 | Pallor (HP:0000980) | 1.94105921 |
| 77 | Medial flaring of the eyebrow (HP:0010747) | 1.93169842 |
| 78 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93025947 |
| 79 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.91536607 |
| 80 | True hermaphroditism (HP:0010459) | 1.90687438 |
| 81 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.89163795 |
| 82 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.89163795 |
| 83 | Increased serum lactate (HP:0002151) | 1.89141698 |
| 84 | Septo-optic dysplasia (HP:0100842) | 1.88673864 |
| 85 | Type 2 muscle fiber atrophy (HP:0003554) | 1.86439019 |
| 86 | Abnormality of magnesium homeostasis (HP:0004921) | 1.85571983 |
| 87 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.85021822 |
| 88 | Nonprogressive disorder (HP:0003680) | 1.84627863 |
| 89 | Hyperventilation (HP:0002883) | 1.83892036 |
| 90 | Hypoplasia of the uterus (HP:0000013) | 1.82507947 |
| 91 | Abnormal eating behavior (HP:0100738) | 1.82346318 |
| 92 | Respiratory difficulties (HP:0002880) | 1.79049829 |
| 93 | Abnormal number of incisors (HP:0011064) | 1.77841898 |
| 94 | Muscle fiber atrophy (HP:0100295) | 1.77520385 |
| 95 | Abnormal urine phosphate concentration (HP:0012599) | 1.77233678 |
| 96 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.77066580 |
| 97 | Tetany (HP:0001281) | 1.75171423 |
| 98 | Abnormality of the aortic arch (HP:0012303) | 1.73724874 |
| 99 | Reticulocytopenia (HP:0001896) | 1.73560284 |
| 100 | Restlessness (HP:0000711) | 1.72874628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 3.45995641 |
| 2 | PINK1 | 3.25114976 |
| 3 | NME2 | 2.88432860 |
| 4 | NTRK3 | 2.68776716 |
| 5 | DMPK | 2.67125552 |
| 6 | PAK3 | 2.44283573 |
| 7 | WNK4 | 2.14016621 |
| 8 | PRKCG | 2.12381684 |
| 9 | CDC7 | 1.86316626 |
| 10 | NTRK2 | 1.75279291 |
| 11 | UHMK1 | 1.74489881 |
| 12 | CASK | 1.71914080 |
| 13 | DAPK2 | 1.68236791 |
| 14 | CAMKK2 | 1.67957727 |
| 15 | STK39 | 1.65100583 |
| 16 | MINK1 | 1.61843550 |
| 17 | EPHA4 | 1.59651568 |
| 18 | BUB1 | 1.58298586 |
| 19 | TNIK | 1.55830912 |
| 20 | CAMK2A | 1.51347996 |
| 21 | ADRBK2 | 1.46115449 |
| 22 | MARK1 | 1.43086484 |
| 23 | CAMK1 | 1.40508741 |
| 24 | GRK5 | 1.38438978 |
| 25 | MAP3K4 | 1.38364779 |
| 26 | PAK6 | 1.37438594 |
| 27 | FRK | 1.35551515 |
| 28 | CAMK2B | 1.30900904 |
| 29 | TAF1 | 1.27641541 |
| 30 | VRK2 | 1.22861355 |
| 31 | DAPK1 | 1.18755630 |
| 32 | MAP2K7 | 1.17430251 |
| 33 | SGK494 | 1.13839640 |
| 34 | SGK223 | 1.13839640 |
| 35 | PNCK | 1.13795479 |
| 36 | ABL2 | 1.13752300 |
| 37 | CAMK2G | 1.09381774 |
| 38 | IRAK2 | 1.08677562 |
| 39 | CAMKK1 | 1.06304304 |
| 40 | NUAK1 | 1.05681856 |
| 41 | CAMK2D | 1.05442359 |
| 42 | RIPK4 | 1.05229555 |
| 43 | BRAF | 1.04492142 |
| 44 | TAOK3 | 1.01926312 |
| 45 | PIK3CA | 1.00163082 |
| 46 | DYRK2 | 0.99318645 |
| 47 | GRK1 | 0.97474241 |
| 48 | CSNK1E | 0.96518726 |
| 49 | CSNK1G2 | 0.96093015 |
| 50 | CDK5 | 0.96091907 |
| 51 | PTK2B | 0.93918921 |
| 52 | MAP3K9 | 0.93447174 |
| 53 | PLK2 | 0.89644650 |
| 54 | CDK14 | 0.89284255 |
| 55 | TEC | 0.87953062 |
| 56 | SGK1 | 0.87331014 |
| 57 | TLK1 | 0.86018422 |
| 58 | BMPR1B | 0.84384978 |
| 59 | PRKCZ | 0.84328963 |
| 60 | CDK15 | 0.82266995 |
| 61 | PDK2 | 0.81256187 |
| 62 | PRKCQ | 0.80927039 |
| 63 | SGK2 | 0.80652930 |
| 64 | CDK11A | 0.80167137 |
| 65 | STK11 | 0.80133522 |
| 66 | MAP3K12 | 0.78157885 |
| 67 | MAPKAPK5 | 0.77729755 |
| 68 | PRKACA | 0.73371636 |
| 69 | CDK18 | 0.71903042 |
| 70 | AURKA | 0.71223267 |
| 71 | BCKDK | 0.71041739 |
| 72 | MAP2K4 | 0.70859381 |
| 73 | LIMK1 | 0.69268180 |
| 74 | MAPK13 | 0.69067798 |
| 75 | CSNK1G3 | 0.68739212 |
| 76 | OXSR1 | 0.67600958 |
| 77 | DYRK1A | 0.67042533 |
| 78 | PRKG1 | 0.65706706 |
| 79 | ADRBK1 | 0.64124020 |
| 80 | CSNK1A1 | 0.63646508 |
| 81 | PRKCA | 0.62430492 |
| 82 | PKN1 | 0.62273825 |
| 83 | CSNK2A2 | 0.62004926 |
| 84 | ARAF | 0.61469255 |
| 85 | MAPKAPK3 | 0.60718941 |
| 86 | ILK | 0.60708564 |
| 87 | RPS6KA3 | 0.60362812 |
| 88 | MAPK12 | 0.60023150 |
| 89 | PAK1 | 0.58977405 |
| 90 | CDK19 | 0.58225569 |
| 91 | INSRR | 0.57749375 |
| 92 | MAP3K11 | 0.56903880 |
| 93 | PRKCI | 0.55590975 |
| 94 | DAPK3 | 0.55204568 |
| 95 | PRKCD | 0.54629276 |
| 96 | CSNK1G1 | 0.52636060 |
| 97 | CAMK1G | 0.47838477 |
| 98 | WNK3 | 0.47625252 |
| 99 | PRKCH | 0.47245488 |
| 100 | MAPK10 | 0.46439014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.73758643 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.60837502 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.78282072 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.53874545 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 3.52822433 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 3.11024294 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.96755383 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.48913734 |
| 9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.44022297 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.21444037 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.21421121 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.99859156 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.84587435 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.81314265 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.78932160 |
| 16 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.78381561 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.67350202 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.65667552 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64305246 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.53300700 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.45983433 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.42587791 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.41655265 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37852676 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.33688989 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.31715156 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31494575 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.30001112 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25972492 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.23425732 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18627049 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16570362 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.15449173 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13939896 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12448347 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.11861906 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.07974409 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07871130 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.07471856 |
| 40 | Renin secretion_Homo sapiens_hsa04924 | 0.99782178 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93612614 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90238076 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88972789 |
| 44 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84941961 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84465240 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83377769 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.81693471 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 0.76258555 |
| 49 | Protein export_Homo sapiens_hsa03060 | 0.75880904 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71830164 |
| 51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65300843 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64233739 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63312645 |
| 54 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.60815666 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57411949 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55845646 |
| 57 | Long-term depression_Homo sapiens_hsa04730 | 0.55761904 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.53040770 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52541085 |
| 60 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51395011 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50241961 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49700732 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48032026 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47812389 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47544501 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46566064 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44375425 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42865062 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42426605 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41902627 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41831920 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40260397 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38537822 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37963755 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37359453 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37271751 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.37114714 |
| 78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36459919 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36382292 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36326233 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35254926 |
| 82 | Peroxisome_Homo sapiens_hsa04146 | 0.35019932 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.31603242 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30844262 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30047914 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28093927 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25663493 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.23182620 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22942595 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.20741169 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.20380493 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.19432543 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18287163 |
| 94 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.18249302 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.16976253 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.15957031 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.15687547 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15633357 |
| 99 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.14994215 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.14789443 |

